NB
Insider
Nicholas A.J. Botwood
Head of R&D, CMONicholas A.J. Botwood (Head of R&D, CMO) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Syndax Pharmaceuticals, Inc. (SNDX). The largest single filing was $1.2M of SNDX (65,515 sh across 2 lots, as filed), executed Jun 11.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.2M
shares × price, as filed
Last traded
Jun 12
Filed Jun 12
Median ADV $36.8M across their filed names
Open performance→Volume by month
Buys $106K
Sells $1.2M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
SNDXRecent filings
SNDXSALE
Syndax Pharmaceuticals, Inc.
View filing →
$1.2M65,515 sh across 2 lots
Exec Jun 11
Filed Jun 12 · 5:30 PM ET SNDXPURCHASE Syndax Pharmaceuticals, Inc. View filing → $106K
11,765 sh × $9.00
Exec May 16 2025
Filed May 19 2025 · 5:30 PM ET